These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 29288190)
1. Can we Rombouts AJM; Al-Najami I; Abbott NL; Appelt A; Baatrup G; Bach S; Bhangu A; Garm Spindler KL; Gray R; Handley K; Kaur M; Kerkhof E; Kronborg CJ; Magill L; Marijnen CAM; Nagtegaal ID; Nyvang L; Peters FP; Pfeiffer P; Punt C; Quirke P; Sebag-Montefiore D; Teo M; West N; de Wilt JHW; BMJ Open; 2017 Dec; 7(12):e019474. PubMed ID: 29288190 [TBL] [Abstract][Full Text] [Related]
2. Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches. Bach SP; Colorectal Dis; 2022 May; 24(5):639-651. PubMed ID: 35114057 [TBL] [Abstract][Full Text] [Related]
3. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Bach SP; Gilbert A; Brock K; Korsgen S; Geh I; Hill J; Gill T; Hainsworth P; Tutton MG; Khan J; Robinson J; Steward M; Cunningham C; Levy B; Beveridge A; Handley K; Kaur M; Marchevsky N; Magill L; Russell A; Quirke P; West NP; Sebag-Montefiore D; Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):92-105. PubMed ID: 33308452 [TBL] [Abstract][Full Text] [Related]
5. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP; Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740 [TBL] [Abstract][Full Text] [Related]
6. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study). Serra-Aracil X; Pericay C; Badia-Closa J; Golda T; Biondo S; Hernández P; Targarona E; Borda-Arrizabalaga N; Reina A; Delgado S; Vallribera F; Caro A; Gallego-Plazas J; Pascual M; Álvarez-Laso C; Guadalajara-Labajo HG; Mora-Lopez L Ann Oncol; 2023 Jan; 34(1):78-90. PubMed ID: 36220461 [TBL] [Abstract][Full Text] [Related]
7. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation. Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984 [TBL] [Abstract][Full Text] [Related]
8. The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery. Bökkerink GM; de Graaf EJ; Punt CJ; Nagtegaal ID; Rütten H; Nuyttens JJ; van Meerten E; Doornebosch PG; Tanis PJ; Derksen EJ; Dwarkasing RS; Marijnen CA; Cats A; Tollenaar RA; de Hingh IH; Rutten HJ; van der Schelling GP; Ten Tije AJ; Leijtens JW; Lammering G; Beets GL; Aufenacker TJ; Pronk A; Manusama ER; Hoff C; Bremers AJ; Verhoef C; de Wilt JH BMC Surg; 2011 Dec; 11():34. PubMed ID: 22171697 [TBL] [Abstract][Full Text] [Related]
9. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274 [TBL] [Abstract][Full Text] [Related]
10. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907 [TBL] [Abstract][Full Text] [Related]
11. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526 [TBL] [Abstract][Full Text] [Related]
12. Optimisation of Organ Preservation treatment strategies in patients with rectal cancer with a good clinical response after neoadjuvant (chemo)radiotherapy: Additional contact X-ray brachytherapy versus eXtending the observation period and local excision (OPAXX) - protocol for two multicentre, parallel, single-arm, phase II studies. Geubels BM; van Triest B; Peters FP; Maas M; Beets GL; Marijnen CAM; Custers PA; Rutten HJT; Theuws JCM; Verrijssen AE; Cnossen JS; Burger JWA; Grotenhuis BA BMJ Open; 2023 Dec; 13(12):e076866. PubMed ID: 38159950 [TBL] [Abstract][Full Text] [Related]
13. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521 [TBL] [Abstract][Full Text] [Related]
15. Robotic transanal surgery for local excision of rectal neoplasia, transanal total mesorectal excision, and repair of complex fistulae: clinical experience with the first 18 cases at a single institution. Atallah S; Martin-Perez B; Parra-Davila E; deBeche-Adams T; Nassif G; Albert M; Larach S Tech Coloproctol; 2015 Jul; 19(7):401-10. PubMed ID: 25708682 [TBL] [Abstract][Full Text] [Related]
16. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T Serra-Aracil X; Pericay C; Golda T; Mora L; Targarona E; Delgado S; Reina A; Vallribera F; Enriquez-Navascues JM; Serra-Pla S; Garcia-Pacheco JC; Int J Colorectal Dis; 2018 Feb; 33(2):241-249. PubMed ID: 29234923 [TBL] [Abstract][Full Text] [Related]
17. Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review. Allaix ME; Arezzo A; Morino M Surg Endosc; 2016 Nov; 30(11):4841-4852. PubMed ID: 26902614 [TBL] [Abstract][Full Text] [Related]
18. National Early Rectal Cancer Treatment Revisited. Stornes T; Wibe A; Nesbakken A; Myklebust TÅ; Endreseth BH Dis Colon Rectum; 2016 Jul; 59(7):623-9. PubMed ID: 27270514 [TBL] [Abstract][Full Text] [Related]
19. Utility Scores and Preferences for Surgical and Organ-Sparing Approaches for Treatment of Intermediate and High-Risk Rectal Cancer. Couwenberg AM; Intven MPW; Burbach JPM; Emaus MJ; van Grevenstein WMU; Verkooijen HM Dis Colon Rectum; 2018 Aug; 61(8):911-919. PubMed ID: 29697477 [TBL] [Abstract][Full Text] [Related]
20. Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign. Rupinski M; Szczepkowski M; Malinowska M; Mroz A; Pietrzak L; Wyrwicz L; Rutkowski A; Bujko K Eur J Surg Oncol; 2016 Feb; 42(2):288-96. PubMed ID: 26506863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]